Related Experiment Video

Updated: Jul 15, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Pharmacodiagnostics and targeted therapies - a rational approach for individualizing medical anticancer therapy in

Jan Trøst Jørgensen1, Kirsten Vang Nielsen, Bent Ejlertsen

  • 1Clinical Research, Dako Denmark A/S, Produktionsvej 42, DK-2600 Glostrup, Denmark. jan.trost@dako.com

The Oncologist
|May 2, 2007
PubMed

Insights

Pharmacodiagnostic tests are crucial for personalized breast cancer treatment, identifying patients likely to benefit from targeted therapies. These tests guide rational pharmacotherapy, moving oncology towards individualized medicine.

Area of Science:

  • Oncology
  • Pharmacology
  • Biomarker Discovery

Background:

  • Breast cancer therapy selection traditionally relies on population-based clinical trial data.
  • Rational pharmacotherapy necessitates matching specific drugs to individual patients.
  • Pharmacodiagnostic tests are essential tools for guiding this personalized selection process.

Purpose of the Study:

  • To highlight the indispensable role of pharmacodiagnostic tests in modern breast cancer treatment.
  • To discuss the development and application of pharmacodiagnostic tests for targeted therapies.
  • To emphasize the contribution of these tests to the advancement of individualized cancer medicine.

Main Methods:

  • Development of pharmacodiagnostic tests for targeted therapies (e.g., antiestrogens, HER2 inhibitors).
  • Utilizing tumor biopsy samples to detect predictive biomarkers.
  • Employing technologies such as immunohistochemistry and in situ hybridization (FISH, CISH).

Main Results:

  • Pharmacodiagnostic tests can identify patients with a high probability of benefiting from specific targeted therapies.
  • Detection of predictive biomarkers is achieved through various established molecular pathology techniques.
  • These tests are integral to the efficacy of targeted drug selection.

Conclusions:

  • Pharmacodiagnostic tests are pivotal for the future development of targeted cancer therapies.
  • These tests are a prerequisite for the successful implementation of individualized medicine in oncology.
  • The integration of pharmacodiagnostics enhances the precision of breast cancer treatment strategies.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...